search
Back to results

Effectiveness of a Community-delivered Integrated Malaria Elimination (CIME) Model in Myanmar

Primary Purpose

Malaria

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Community-delivered Integrated Malaria Elimination (CIME) intervention model
Sponsored by
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Malaria focused on measuring Community-delivered, Intervention, elimination, falciparum, vivax, routine testing, Stepped-wedge

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Villages in Ayeyarwaddy, Bago and Yangon Regions and Kayah State townships in Myanmar with National Malaria Control Program (NMCP) trained Integrated Community Malaria Volunteers (ICMVs).

Exclusion Criteria:

  • Townships

A township will be excluded from the study if:

  1. The township does not have an NMCP provided ICMV network
  2. The township has ongoing armed conflict
  3. The township does not have Vector-Borne Diseases Control (VBDC) staff or malaria focal person
  4. The location of the township is not geographically or politically feasible for staff from the State/Regional capital city to conduct regular supervision visits

Villages

After selection of 8 townships (2 townships from each state/region), villages in the townships will be screened against the exclusion criteria. A village will be excluded from the study if:

  1. The village is too remote and unable to execute the CIME model completely,
  2. The village has a government public health facility,
  3. The village has no mobile network coverage
  4. The village is in the ongoing armed conflict zone , or
  5. The village has an ICMV program operated by any organizations other than NMCP
  6. The village has an Annual Parasite Index (API) >=5

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    No Intervention

    Arm Label

    CIME intervention

    ICMV standard of care

    Arm Description

    Community-delivered Integrated Malaria Elimination (CIME). The CIME intervention model integrates interventions for malaria, dengue, tuberculosis, childhood diarrhoea and RDT-negative fever.

    Integrated Community Malaria Volunteer (ICMV) model - this is the current standard of care. This model involves malaria volunteers undertaking additional screening and referral services for a range of other diseases including: dengue, lymphatic filariasis, tuberculosis, HIV/AIDS and leprosy.

    Outcomes

    Primary Outcome Measures

    Blood examination rate
    Change in blood examination rate as determined by the number of rapid diagnostic tests (RDTs) for malaria performed per week per village

    Secondary Outcome Measures

    Plasmodium spp. infection detected by RDT
    Change in the number of Plasmodium spp. infections detected by RDT per week per village
    Plasmodium spp. infections reported with 24 hours
    Change in the number and percentage of Plasmodium spp. infections reported within 24 hours of RDT per village
    Plasmodium spp. infection detected by PCR
    Change in the number of Plasmodium spp. infections detected by polymerase chain reaction (PCR) (from RDT cassette) per week
    Larval source management
    Change in the number of larval sources managed by the volunteer per week
    Dengue cases
    Change in the number of suspected Dengue cases referred to the nearby clinic per week
    Tuberculosis (TB) cases
    Change in the number of suspected tuberculosis cases referred for diagnosis to national tuberculosis program per week
    TB DOTS
    Number of TB patients monitored by volunteer for DOTS over the whole study period
    Diarrheal cases diagnosed, treated and referred
    Change in the number of diarrheal cases diagnosed, treated with ORS and zinc tablets and referred per week
    RDT-negative fever cases
    Change in the number of RDT-negative fever cases referred per week
    Malaria treatment according to national policy
    Change in the proportion of patients with confirmed malaria who received first-line antimalarial treatment according to national policy
    Data accuracy and completeness in reporting of malaria cases
    Change in the number of accurately reported and complete malaria case records according the national malaria case-based reporting format
    Malaria drug resistance-associated mutations
    Change in the proportion of Kelch13 and other resistance mutations detected by PCR from RDT cassettes
    Seroprevalence of malaria-associated antibodies
    Change in the seroprevalence of anti-malarial antibodies detected by enzyme-linked immunosorbent assay (ELISA) from RDT cassette
    Levels of malaria-associated antibodies
    Change in the levels of anti-malarial antibodies detected by enzyme-linked immunosorbent assay (ELISA) from RDT cassette
    Acceptability of the CIME model by villagers
    Acceptability of the CIME model by villagers assessed by an investigator-developed questionnaire including component constructs such as affective attitude, burden, perceived effectiveness and self-efficacy.
    Acceptability of the CIME model by CIME volunteers
    Acceptability of the CIME model by CIME volunteers assessed by an investigator-developed questionnaire including component constructs such as affective attitude, burden, perceived effectiveness and self-efficacy.
    Acceptability of the CIME model by stakeholders
    Acceptability of the CIME model by stakeholders assessed by focus group discussions.
    Cost-effectiveness of the CIME model
    Cost-effectiveness of the CIME model compared to ICMV model (Cost per unit detection, treatment and notification of a malaria case)

    Full Information

    First Posted
    December 19, 2020
    Last Updated
    January 3, 2021
    Sponsor
    Macfarlane Burnet Institute for Medical Research and Public Health Ltd
    Collaborators
    National Malaria Control Program, Myanmar
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04695886
    Brief Title
    Effectiveness of a Community-delivered Integrated Malaria Elimination (CIME) Model in Myanmar
    Official Title
    Evaluation of the Effectiveness and Cost-effectiveness of a Community-delivered Integrated Malaria Elimination (CIME) Model in Myanmar: An Open Stepped-wedge Cluster-randomised Controlled Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    January 2021
    Overall Recruitment Status
    Unknown status
    Study Start Date
    January 2021 (Anticipated)
    Primary Completion Date
    July 2021 (Anticipated)
    Study Completion Date
    July 2021 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Macfarlane Burnet Institute for Medical Research and Public Health Ltd
    Collaborators
    National Malaria Control Program, Myanmar

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    In Myanmar, community health workers, known as malaria volunteers, have played a key role in reducing the malaria burden in the malaria control phase, providing essential malaria services in rural areas where the coverage of formal health services is limited. However, the community-delivered models that have worked well for malaria control may not work well for malaria elimination. In parallel with switching from interventions for malaria control to those for elimination, the motivation and social importance of malaria volunteers has declined along with the decline of the malaria burden. To sustain volunteer motivation, the social importance and effectiveness in the malaria elimination program, the Community-delivered Integrated Malaria Elimination model for Myanmar (CIME model) was developed based on global evidence and qualitative consultations with community members, leaders, volunteers and health stakeholders in Myanmar. This study will assess the level of effectiveness of the CIME model in increasing malaria testing by its application in an open cluster-randomised controlled stepped-wedge trial.
    Detailed Description
    The CIME model integrates interventions for malaria, dengue, tuberculosis, childhood diarrhoea and Rapid Diagnostic Test (RDT)-negative fever. It will involve the recruitment and training of a volunteer to implement the CIME model in each village. The primary outcome of the trial is blood examination rate as determined by number of RDTs for malaria performed per week per village. 140 villages in 8 townships across Ayeyarwaddy, Bago and Yangon Regions and Kayah State in Myanmar will be sampled at random with probability proportional to size. Study populations include villages with ICMVs who will be re-trained as CIME volunteers (intervention phase) and the community members in the service catchment areas of those volunteers. An open stepped-wedge cluster-randomised controlled trial, randomized at the volunteer level (i.e. the volunteer and the village / workplaces they service), will be conducted over 6-months to evaluate the effectiveness and cost-effectiveness of the CIME model intervention. The stepped-wedge design will comprises 24 weekly measurements of the number of malaria blood examinations performed by each village, with villages grouped into 10 blocks of 14 villages and transitioned from control to intervention phases at bi-weekly intervals following a universal two-week control period. Differences in the per weekly rate of blood examination (primary outcome), will be estimated across intervention and control phases using a generalised linear (e.g. Poisson or negative-binomial link functions) mixed modelling analytical approach with maximum likelihood estimation.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Malaria
    Keywords
    Community-delivered, Intervention, elimination, falciparum, vivax, routine testing, Stepped-wedge

    7. Study Design

    Primary Purpose
    Health Services Research
    Study Phase
    Not Applicable
    Interventional Study Model
    Crossover Assignment
    Model Description
    Stepped-wedge cluster randomized control trial (one-way crossover)
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    6440 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    CIME intervention
    Arm Type
    Experimental
    Arm Description
    Community-delivered Integrated Malaria Elimination (CIME). The CIME intervention model integrates interventions for malaria, dengue, tuberculosis, childhood diarrhoea and RDT-negative fever.
    Arm Title
    ICMV standard of care
    Arm Type
    No Intervention
    Arm Description
    Integrated Community Malaria Volunteer (ICMV) model - this is the current standard of care. This model involves malaria volunteers undertaking additional screening and referral services for a range of other diseases including: dengue, lymphatic filariasis, tuberculosis, HIV/AIDS and leprosy.
    Intervention Type
    Other
    Intervention Name(s)
    Community-delivered Integrated Malaria Elimination (CIME) intervention model
    Intervention Description
    Malaria: Malaria Diagnosis using RDT, treatment, referral and reporting; Prevention interventions (Behavioral Change Communication, net and repellent distribution); assisting in case and foci investigation and larval source management. Dengue: Assisting in dengue prevention; Referral of cases. Tuberculosis (TB): Detection and referral of suspected cases; Contact tracing; Directly observed treatment, short-course (DOTS) providers; defaulter tracing; follow-up sputum examinations; assisting in TB health education talks and active case detection activities. Childhood diarrhea: Prevention; Health education and Water, sanitation and hygiene (WASH) promotion; Diagnosis and dehydration assessment; Treatment and referral; Rehydration therapy using Oral Rehydration Solution (ORS) and oral Zinc tablet; assisted referral. RDT-negative fever: Prevention and health education; Symptomatic treatment with antipyretics and immediate assisted referral.
    Primary Outcome Measure Information:
    Title
    Blood examination rate
    Description
    Change in blood examination rate as determined by the number of rapid diagnostic tests (RDTs) for malaria performed per week per village
    Time Frame
    Assessed weekly, longitudinally over 6-months
    Secondary Outcome Measure Information:
    Title
    Plasmodium spp. infection detected by RDT
    Description
    Change in the number of Plasmodium spp. infections detected by RDT per week per village
    Time Frame
    Assessed weekly, longitudinally over 6-months.
    Title
    Plasmodium spp. infections reported with 24 hours
    Description
    Change in the number and percentage of Plasmodium spp. infections reported within 24 hours of RDT per village
    Time Frame
    Assessed weekly, longitudinally over 6-months.
    Title
    Plasmodium spp. infection detected by PCR
    Description
    Change in the number of Plasmodium spp. infections detected by polymerase chain reaction (PCR) (from RDT cassette) per week
    Time Frame
    Assessed weekly, longitudinally over 6-months.
    Title
    Larval source management
    Description
    Change in the number of larval sources managed by the volunteer per week
    Time Frame
    Assessed weekly, longitudinally over 6-months.
    Title
    Dengue cases
    Description
    Change in the number of suspected Dengue cases referred to the nearby clinic per week
    Time Frame
    Assessed weekly, longitudinally over 6-months.
    Title
    Tuberculosis (TB) cases
    Description
    Change in the number of suspected tuberculosis cases referred for diagnosis to national tuberculosis program per week
    Time Frame
    Assessed weekly, longitudinally over 6-months
    Title
    TB DOTS
    Description
    Number of TB patients monitored by volunteer for DOTS over the whole study period
    Time Frame
    6-month
    Title
    Diarrheal cases diagnosed, treated and referred
    Description
    Change in the number of diarrheal cases diagnosed, treated with ORS and zinc tablets and referred per week
    Time Frame
    Assessed weekly, longitudinally over 6-months
    Title
    RDT-negative fever cases
    Description
    Change in the number of RDT-negative fever cases referred per week
    Time Frame
    Assessed weekly, longitudinally over 6-months
    Title
    Malaria treatment according to national policy
    Description
    Change in the proportion of patients with confirmed malaria who received first-line antimalarial treatment according to national policy
    Time Frame
    Assessed weekly, longitudinally over 6-months
    Title
    Data accuracy and completeness in reporting of malaria cases
    Description
    Change in the number of accurately reported and complete malaria case records according the national malaria case-based reporting format
    Time Frame
    Assessed weekly, longitudinally over 6-months
    Title
    Malaria drug resistance-associated mutations
    Description
    Change in the proportion of Kelch13 and other resistance mutations detected by PCR from RDT cassettes
    Time Frame
    Assessed weekly, longitudinally over 6-months
    Title
    Seroprevalence of malaria-associated antibodies
    Description
    Change in the seroprevalence of anti-malarial antibodies detected by enzyme-linked immunosorbent assay (ELISA) from RDT cassette
    Time Frame
    Assessed weekly, longitudinally over 6-months
    Title
    Levels of malaria-associated antibodies
    Description
    Change in the levels of anti-malarial antibodies detected by enzyme-linked immunosorbent assay (ELISA) from RDT cassette
    Time Frame
    Assessed weekly, longitudinally over 6-months
    Title
    Acceptability of the CIME model by villagers
    Description
    Acceptability of the CIME model by villagers assessed by an investigator-developed questionnaire including component constructs such as affective attitude, burden, perceived effectiveness and self-efficacy.
    Time Frame
    6-month
    Title
    Acceptability of the CIME model by CIME volunteers
    Description
    Acceptability of the CIME model by CIME volunteers assessed by an investigator-developed questionnaire including component constructs such as affective attitude, burden, perceived effectiveness and self-efficacy.
    Time Frame
    6-month
    Title
    Acceptability of the CIME model by stakeholders
    Description
    Acceptability of the CIME model by stakeholders assessed by focus group discussions.
    Time Frame
    6-month
    Title
    Cost-effectiveness of the CIME model
    Description
    Cost-effectiveness of the CIME model compared to ICMV model (Cost per unit detection, treatment and notification of a malaria case)
    Time Frame
    6-month

    10. Eligibility

    Sex
    All
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Villages in Ayeyarwaddy, Bago and Yangon Regions and Kayah State townships in Myanmar with National Malaria Control Program (NMCP) trained Integrated Community Malaria Volunteers (ICMVs). Exclusion Criteria: Townships A township will be excluded from the study if: The township does not have an NMCP provided ICMV network The township has ongoing armed conflict The township does not have Vector-Borne Diseases Control (VBDC) staff or malaria focal person The location of the township is not geographically or politically feasible for staff from the State/Regional capital city to conduct regular supervision visits Villages After selection of 8 townships (2 townships from each state/region), villages in the townships will be screened against the exclusion criteria. A village will be excluded from the study if: The village is too remote and unable to execute the CIME model completely, The village has a government public health facility, The village has no mobile network coverage The village is in the ongoing armed conflict zone , or The village has an ICMV program operated by any organizations other than NMCP The village has an Annual Parasite Index (API) >=5
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Freya Fowkes, DPhil
    Phone
    +61385062310
    Email
    freya.fowkes@burnet.edu.au
    First Name & Middle Initial & Last Name or Official Title & Degree
    Win Han Oo, PhD
    Phone
    +951375785
    Email
    winhan.oo@burnet.edu.au
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Freya Fowkes, DPhil
    Organizational Affiliation
    Burnet Institute
    Official's Role
    Principal Investigator
    First Name & Middle Initial & Last Name & Degree
    Win Han Oo, PhD
    Organizational Affiliation
    Burnet Institute
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    Yes
    IPD Sharing Plan Description
    De-identified individual participant data will be available after publication from the data custodian(s) to applicants who provide a sound proposal to The Ethics Review Committee on Medical Research Involving Human Subjects, Department of Medical Research, Myanmar Ministry of Health and Sports (No. 5 Ziwaka Road, Dagon PO Yangon, Myanmar; (+95) 01 375447 extension 118; ercdmr2015@gmail.com) contingent of their approval.
    IPD Sharing Time Frame
    Supporting information will be published in peer-reviewed journals within 2 years of study completion.
    IPD Sharing Access Criteria
    Supporting information can be requested from study investigators
    Citations:
    PubMed Identifier
    34389579
    Citation
    Oo WH, Thi A, Htike W, Agius PA, Cutts JC, Win KM, Yi Linn NY, Than WP, Hkawng GN, Thu KM, Oo MC, O'Flaherty K, Kearney E, Scott N, Phyu PP, Htet AT, Myint O, Lwin Yee L, Thant ZP, Mon A, Htike S, Hnin TP, Fowkes FJI. Evaluation of the effectiveness and cost effectiveness of a Community-delivered Integrated Malaria Elimination (CIME) model in Myanmar: protocol for an open stepped-wedge cluster-randomised controlled trial. BMJ Open. 2021 Aug 13;11(8):e050400. doi: 10.1136/bmjopen-2021-050400.
    Results Reference
    derived

    Learn more about this trial

    Effectiveness of a Community-delivered Integrated Malaria Elimination (CIME) Model in Myanmar

    We'll reach out to this number within 24 hrs